Stephen B. Solomon, MD

Section Chief
Memorial Sloan Kettering Cancer Center

Presentation(s):

• Safety and efficacy of percutaneous cryoablation for primary and metastatic intrathoracic, pleural based tumors

  Sunday, March 5, 2023
  4:21 PM – 4:30 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Ablation Techniques for Solid Tumors

  Sunday, March 5, 2023
  5:00 PM – 6:00 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Long-term outcomes of PET-guided Microwave Ablation of Breast Cancer Liver Metastases

  Monday, March 6, 2023
  3:54 PM – 4:03 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Immediate 3D Imaging Assessment is the Most Accurate Predictor of Local Tumor Progression after Microwave Ablation of Colorectal Cancer Liver Metastases

  Tuesday, March 7, 2023
  3:27 PM – 3:36 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Microwave Ablation of Colorectal Cancer Lung Metastases: Single Center 10-year Experience

  Tuesday, March 7, 2023
  3:45 PM – 3:54 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Accuracy of a Cone Beam CT-based Liver-directed Therapy Planning Software for Perfused Parenchyma Prediction

  Wednesday, March 8, 2023
  4:03 PM – 4:12 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Comparison of Perioperative and Procedure Room Times Between Moderate Sedation and Monitored Anesthesia Care in Interventional Radiology

  Wednesday, March 8, 2023
  3:09 PM – 3:18 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)

• Total Lesion Glycolysis and the Impact of Tumor Absorbed Dose Following Radioembolization of Breast Cancer Liver Metastases

  Wednesday, March 8, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): Aperture Medical: Board Membership (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Elesta: Research Grant Recipient (Ongoing); GE Healthcare: Consultant (Ongoing), Research Grant Recipient (Ongoing); Johnson & Johnson: Consultant (Ongoing), Ownership Interest (Ongoing); Microbot: Consultant (Ongoing); XAct Robotics: Consultant (Ongoing)